Clinical trial tests combination antibody therapy in adults with advanced cancer
Credit: Pixabay/CC0 Public Domain In an early-phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer. The findings are published in Cancer, Both medications tested in the trial support immune responses against tumor cells. CS1002 increases the activation …
Clinical trial tests combination antibody therapy in adults with advanced cancer Read More »